Neobes (Diethylpropion) 25 mg
Neobes (Diethylpropion) 25 mg is an appetite suppressant (diet pill) used along with diet, exercise, and behavior therapy for the short-term management of obesity.
Antidiabetic drug requirements (i.e., insulin) may be altered. Concurrent use with general anesthetics may result in arrhythmias. The pressor effects of diethylpropion and those of other drugs may be additive when the drugs are used concomitantly; conversely, diethylpropion may interfere with antihypertensive drugs (i.e., guanethidine, a-methyldopa). Concurrent use of phenothiazines may antagonize the anorectic effect of diethylpropion.
Advanced arteriosclerosis, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma, severe hypertension. Agitated states.
Patients with a history of drug abuse. During or within 14 days following the administration of monoamine oxidase inhibitors, hypertensive crises may result.
The maximum recommended duration of using Neobes 75mg capsules is eight weeks. Longer use of Neobes weight loss drug increases the risk of drug dependence. Neobes 75mg capsules can be used as a repeat anti-obesity therapy. Interval between the courses of obesity drug therapy should be at least two weeks. Total duration of using Neobes 75 capsules should not exceed 12 weeks within a year.
List of Neobes substitutes (brand and generic names): Linea (Italy), Lineal-Rivo,M-Orexic and Magrene. Magrex Retard,Maruate,Maruate and Spantab. Menutil (Belgium), Moderatan (France), Modulor and Nobesine (Canada).